On the last day, Rubicon Research IPO was subscribed 109.35 times overall, a retail quota was 37.40 times, QIB 137.09 times, and 102.70 times for NII.
Details About Rubicon Research IPO
Rubicon Research received approval from SEBI for an IPO of ₹1,377.50 crores, comprising an offer for sale up to 1,80,92,762 equity shares with a face value of ₹10 each. Rubicon Research has set up a ₹461 to ₹485 per share.
In the Rubicon Research IPO, the 1 lot size for the minimum Retail category got 30 shares. The max retail category, 390 shares in 13 lot sizes. S-HNI Maximum category, 420 shares in 14. S-HNI Maximum 2,040 shares in 68 lot sizes. B-HNI Minimum 2,070 shares in 69 lot sizes.
To invest in the Rubicon Research IPO, each investor category has specific investment amounts:
- Retail Investors: Minimum investment of ₹14,550.
- Retail investors’ (Max) investment of ₹1,89,150.
- Small HNI (S-HNI): Minimum investment of ₹2,03,700.
- Small HNI (S-HNI): Maximum investment of ₹9,89,400.
- Big HNI(B-HNI): maximum investment of ₹10,03,950.
Rubicon Research subscription duration
Rubicon Research IPO started on October 9, 2025, and closed on October 13, 2025. The investor’s allotment date was October 14, 2025, and they received a refund on October 15, 2025. The Rubicon Research IPO listing date is October 16, 2025.
About Rubicon Research Company
Founded in 1999, Rubicon Research is one of the growing pharmaceutical formulation companies involved in developing, manufacturing, and commercializing differentiated formulations. Moreover, their portfolio includes specialty products and drug-device combination products, aimed mainly at regulated markets, especially the United States.
Furthermore, they believe their multi-disciplinary, data-driven, and return on investment (“ROI”) centric product selection framework is geared towards identifying sustainable opportunities for new product development. Moreover, they find and go after opportunities that give them an edge by using skills in development, manufacturing, and sales to grow their market share.
Rubicon Research IPO Company Financial Report
The company reported revenue of ₹1,296.22 crores in 2025 against ₹872.39 crores in 2024. The company reported a profit of ₹134.36 crores in 2025 against a profit of ₹91.01 crores in 2024.
